Great news from LifeSciences@Work. After the pitch interviews, three highly promising Erasmus MC spin-offs have been selected to join the Venture Challenge program. Over the course of 10 weeks, the teams will work on their business cases, refine their pitches, and develop their entrepreneurial skills. A fantastic opportunity!
Congratulations to:
- Kingfisher: Taking the guesswork out of coronary stent placement.
Jeroen Wilschut (intervention cardiologist at Erasmus MC), Willem Mees van der Bijl (co-founder of Kingfisher), Wilfred Teunissen (senior product designer at Dune Innovation), and Hugo Stegman (business development manager at TTO Erasmus MC). - RadiGene: Reporter gene technology for radionuclide imaging of gene and cell therapies.
Laura Mezzanotte (Associate Professor of Radiology and Nuclear Medicine, Erasmus MC), Felipe Gama Franceschi (PhD, Erasmus MC), and Siyar Kisin, RTTP (senior business development manager, TTO). - Novel FAP inhibitors for imaging and treatment of cancer
Yann Seimbille (Assistant Professor of Radiopharmaceutical Chemistry, Erasmus MC), Hanyue Ma (postdoctoral researcher, Erasmus MC), and Jofey Chadwick (business development manager, TTO, Erasmus MC).
Stay tuned for more information on our Venture Challenge teams and other exciting initiatives. Let’s make an impact together!
